Skip to main content
. 2021 Mar 18;5(4):e10425. doi: 10.1002/jbm4.10425

Fig 9.

Fig 9

Immunofluorescence staining (Alexa Fluor 594) for CD31 15 days after implantation. Scale bar = 100 μm. (A) Negative staining control (no secondary antibody was used). (B) Calvarial muscle (positive control). (C) Sham (surgical procedure, no bone defects). (D) Empty defect. (E) Uncoated “bare” implant. (F) SiONP2. (G) Percentage area occupied by blood vessels and capillary network relative to sham. SiONP = silicon oxynitrophosphide. **p < 0.01, compared with empty and uncoated “bare” implant groups.